214 related articles for article (PubMed ID: 19917957)
1. Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.
Rajan N; Langtry JA; Ashworth A; Roberts C; Chapman P; Burn J; Trainer AH
Arch Dermatol; 2009 Nov; 145(11):1277-84. PubMed ID: 19917957
[TBL] [Abstract][Full Text] [Related]
2. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
[TBL] [Abstract][Full Text] [Related]
3. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
[TBL] [Abstract][Full Text] [Related]
4. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
[TBL] [Abstract][Full Text] [Related]
5. [Brooke-Spiegler syndrome: an heterogeneous entity].
Mataix J; Bañuls J; Botella R; Laredo C; Lucas A
Actas Dermosifiliogr; 2006 Dec; 97(10):669-72. PubMed ID: 17173833
[TBL] [Abstract][Full Text] [Related]
6. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
7. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene.
Zhang G; Huang Y; Yan K; Li W; Fan X; Liang Y; Sun L; Li H; Zhang S; Gao M; Du W; Yang S; Liu J; Zhang X
Exp Dermatol; 2006 Dec; 15(12):966-70. PubMed ID: 17083363
[TBL] [Abstract][Full Text] [Related]
8. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome.
Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT
Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348
[TBL] [Abstract][Full Text] [Related]
9. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients.
Kazakov DV; Vanecek T; Zelger B; Carlson JA; Spagnolo DV; Schaller J; Nemcova J; Kacerovska D; Vazmitel M; Sangüeza M; Emberger M; Belousova I; Fernandez-Figueras MT; Kempf W; Meyer DR; Rütten A; Baltaci M; Michal M
Am J Dermatopathol; 2011 May; 33(3):251-65. PubMed ID: 21389835
[TBL] [Abstract][Full Text] [Related]
10. Brooke-Spiegler syndrome: report of a case of multiple cylindromas and trichoepitheliomas.
Doherty SD; Barrett TL; Joseph AK
Dermatol Online J; 2008 Jul; 14(7):8. PubMed ID: 18718192
[TBL] [Abstract][Full Text] [Related]
11. A novel germline mutation in the CYLD gene in a Slovak patient with Brooke-Spiegler syndrome.
Kacerovská D; Szép Z; Kolláriková L; Vaneček T; Michal M; Daniš D; Kazakov D
Cesk Patol; 2013 Apr; 49(2):89-92. PubMed ID: 23641715
[TBL] [Abstract][Full Text] [Related]
12. Brooke-Spiegler syndrome with associated pegged teeth.
Carlson RM; Haddad L; Pui JC
Cutis; 2008 Nov; 82(5):345-9. PubMed ID: 19090338
[TBL] [Abstract][Full Text] [Related]
13. New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome.
Scholz IM; Nümann A; Froster UG; Helmbold P; Enk AH; Näher H
J Dtsch Dermatol Ges; 2010 Feb; 8(2):99-101. PubMed ID: 20151946
[TBL] [Abstract][Full Text] [Related]
14. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.
Arefi M; Wilson V; Muthiah S; Zwolinski S; Bajwa D; Brennan P; Blasdale K; Bourn D; Burn J; Santibanez-Koref M; Rajan N
J Am Acad Dermatol; 2019 Dec; 81(6):1300-1307. PubMed ID: 31085270
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.
Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT
J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188
[TBL] [Abstract][Full Text] [Related]
16. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.
van den Ouweland AM; Elfferich P; Lamping R; van de Graaf R; van Veghel-Plandsoen MM; Franken SM; Houweling AC
Fam Cancer; 2011 Mar; 10(1):127-32. PubMed ID: 20972631
[TBL] [Abstract][Full Text] [Related]
17. A new Cylindromatosis (CYLD) gene mutation in a case of Brooke-Spiegler syndrome masquerading as basal cell carcinoma of the eyelids.
Hester CC; Moscato EE; Kazakov DV; Vanecek T; Moretto JC; Seiff SR
Ophthalmic Plast Reconstr Surg; 2013; 29(1):e10-1. PubMed ID: 22689134
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
[TBL] [Abstract][Full Text] [Related]
19. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds.
Nagy N; Rajan N; Farkas K; Kinyó A; Kemény L; Széll M
Acta Derm Venereol; 2013 Nov; 93(6):743-5. PubMed ID: 23584127
[No Abstract] [Full Text] [Related]
20. Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.
Cranston A; Stocken DD; Stamp E; Roblin D; Hamlin J; Langtry J; Plummer R; Ashworth A; Burn J; Rajan N
Trials; 2017 Mar; 18(1):111. PubMed ID: 28270164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]